Biogen Announces Bioverativ As Name Of New Hemophilia-Focused Company
August 09, 2016 at 12:29 PM EDT
Biogen announced its intent to spin-off its hemophilia business in May 2016. The spin-off is planned to be completed in early 2017, subject to the satisfaction of certain conditions.
